AttendMe Owl Logo
AttendMe
Evidence Evolution
Colorectal SurgeryColorectal Surgery

How This Evidence Evolved

Laparoscopic vs Open Colorectal Cancer Surgery

Comparing Minimally Invasive and Open Surgery for Colon and Rectal Cancer

22.1

Timeline

COST
2004
COLOR
2005
MRC CLASICC
2005
ALaCaRT
2015
ACOSOG Z6051
2015
ROLARR
2017
ASCRS/SAGES enhanced-recovery guideline (published 2023)
2023
Trial
Guideline
Approval
Meta-analysis
Signal

Early observations and pilot data that first suggested a new direction

COST compared laparoscopically assisted and open colectomy for colon cancer in a noninferiority trial at 48 institutions. Among 872 randomized patients, 3-year recurrence was similar (16% laparoscopic vs 18% open; P=.32), as was overall survival (86% vs 85%; P=.51). Surgical-wound recurrence was below 1% in both groups. These findings addressed concern about recurrence and supported laparoscopy as an acceptable alternative in the tested colon-cancer population; nonsignificance alone does not establish survival equivalence.
Proof

Landmark RCTs and pivotal trials that established the evidence base

COLOR compared laparoscopic and open colon resection. Laparoscopy reduced blood loss, hastened bowel recovery, and shortened hospital stay; morbidity and mortality at 28 days did not differ. CLASICC included 794 patients with colorectal cancer. Dukes C2 rates and in-hospital mortality did not differ. Positive margin rates were similar except after laparoscopic anterior resection for rectal cancer, where short-term outcomes raised concern. Conversion to open surgery occurred in 29% in CLASICC.
Extension

Follow-up studies, subgroup analyses, and real-world validation

The ROLARR trial (2017) evaluated the next iteration of minimally invasive approaches by comparing robotic-assisted to conventional laparoscopic rectal cancer resection. Among 471 patients randomized at 29 international centers, robotic surgery did not significantly reduce conversion to open laparotomy (OR 0.61, 95% CI 0.31-1.21, p=0.16). These findings tempered enthusiasm for robotic platforms as a transformative advance over standard laparoscopy for rectal cancer, at least in the hands of surgeons with varying robotic experience.
Guidelines

Integration into clinical practice guidelines and recommendations

ASCRS/SAGES 2023 ERAS guidance recommends minimally invasive colorectal surgery when expertise is available and appropriate.
ASCRS/SAGES enhanced-recovery guideline (published 2023)

Use a minimally invasive approach when expertise is available and appropriate (1A).

ASCRS/SAGES enhanced-recovery guideline (published 2023)

For colorectal surgery within an enhanced-recovery pathway, use a minimally invasive approach when appropriate and expertise is available (1A).

Now

Current standard of care and ongoing research directions

Colon and rectal cancer require separate interpretation. COST supports laparoscopic colectomy with similar recurrence outcomes and faster recovery. For rectal cancer, ALaCaRT and ACOSOG Z6051 did not establish laparoscopic noninferiority for their pathological resection endpoints. ROLARR found no significant reduction in conversion to open surgery with robotic assistance. These results make the operation, population, and endpoint central to choosing and assessing a minimally invasive approach.

Landmark Trials in This Story

COST2004Landmark

A comparison of laparoscopically assisted and open colectomy for colon cancer

Recurrence at 3 years: laparoscopic 16% vs open 18% (HR 0.86, 95% CI 0.63–1.17; P=.32)

New England journal of medicineRCTN=872
COLOR2005Landmark

Laparoscopic surgery versus open surgery for colon cancer: short-term outcomes of a randomised trial

Cancer-free survival at 3 years; short-term report: blood loss 100 mL laparoscopic vs 175 mL open

Lancet OncolRCT
MRC CLASICC2005Landmark

Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial

In-hospital death: open 5% vs laparoscopic 4%; margin similarity except rectal anterior resection

LancetRCTN=794
ROLARR2017Landmark

Effect of Robotic-Assisted vs Conventional Laparoscopic Surgery on Risk of Conversion to Open Laparotomy Among Patients Undergoing Resection for Rectal Cancer: The ROLARR Randomized Clinical Trial

Conversion to open laparotomy — robotic vs laparoscopic OR 0.61 (95% CI 0.31-1.21, p=0.16)

JAMARCTN=471
ALaCaRT2015

Effect of Laparoscopic-Assisted Resection vs Open Resection on Pathological Outcomes in Rectal Cancer: The ALaCaRT Randomized Clinical Trial.

Successful resection: laparoscopic 82% vs open 89% (difference -7.0%, 95% CI -12.4% to infinity; noninferiority P=0.38)

JAMARandomized noninferiority trialN=475
ACOSOG Z60512015

Effect of Laparoscopic-Assisted Resection vs Open Resection of Stage II or III Rectal Cancer on Pathologic Outcomes: The ACOSOG Z6051 Randomized Clinical Trial.

Successful resection: laparoscopic 81.7% vs open 86.9% (noninferiority P=0.41)

JAMARandomized noninferiority trialN=486

Explore the evidence yourself

Ask AttendMe about any trial, guideline, or clinical question. Evidence-ranked answers from 3.7M+ peer-reviewed articles.

Related Evidence

Frequently Asked Questions

Is laparoscopic surgery as effective as open surgery for colon cancer?+
COST reported similar recurrence at 3 years after laparoscopic or open colectomy (16% versus 18%) and similar survival (86% versus 85%). COLOR found faster recovery and similar 28-day morbidity and mortality. CLASICC found similar short-term colon outcomes, with concerns after laparoscopic rectal anterior resection. These reports do not establish identical 5-year results across all trials.
Does robotic surgery offer advantages over laparoscopic surgery for rectal cancer?+
ROLARR randomized 471 patients and found no significant reduction in conversion to open surgery with robotic versus conventional laparoscopy (8.1% vs 12.2%; adjusted OR 0.61, 95% CI 0.31–1.21; P=.16). The reported secondary outcomes also did not differ significantly. These findings do not establish routine clinical superiority.

Medical Disclaimer: This content is for educational purposes only and does not constitute medical advice. Clinical decisions should always be based on individual patient assessment, local guidelines, and professional judgement.

All data sourced from published, peer-reviewed articles and clinical practice guidelines.

Claims checked against cited sources: 10 November 2026